These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 19544453)

  • 61. HDAC4 and HDAC6 sustain DNA double strand break repair and stem-like phenotype by promoting radioresistance in glioblastoma cells.
    Marampon F; Megiorni F; Camero S; Crescioli C; McDowell HP; Sferra R; Vetuschi A; Pompili S; Ventura L; De Felice F; Tombolini V; Dominici C; Maggio R; Festuccia C; Gravina GL
    Cancer Lett; 2017 Jul; 397():1-11. PubMed ID: 28342984
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Activation of Aurora A kinase through the FGF1/FGFR signaling axis sustains the stem cell characteristics of glioblastoma cells.
    Hsu YC; Kao CY; Chung YF; Lee DC; Liu JW; Chiu IM
    Exp Cell Res; 2016 Jun; 344(2):153-66. PubMed ID: 27138904
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anti-Proliferative Effects of E2F1 Suppression in Glioblastoma Cells.
    Godoy PRDV; Donaires FS; Montaldi APL; Sakamoto-Hojo ET
    Cytogenet Genome Res; 2021; 161(6-7):372-381. PubMed ID: 34482308
    [TBL] [Abstract][Full Text] [Related]  

  • 64. STAT3 is required for proliferation and maintenance of multipotency in glioblastoma stem cells.
    Sherry MM; Reeves A; Wu JK; Cochran BH
    Stem Cells; 2009 Oct; 27(10):2383-92. PubMed ID: 19658181
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151.
    Tilghman J; Schiapparelli P; Lal B; Ying M; Quinones-Hinojosa A; Xia S; Laterra J
    Neoplasia; 2016 Mar; 18(3):185-98. PubMed ID: 26992919
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Aberrant mesenchymal differentiation of glioma stem-like cells: implications for therapeutic targeting.
    Balasubramaniyan V; Vaillant B; Wang S; Gumin J; Butalid ME; Sai K; Mukheef F; Kim SH; Boddeke HW; Lang F; Aldape K; Sulman EP; Bhat KP; Colman H
    Oncotarget; 2015 Oct; 6(31):31007-17. PubMed ID: 26307681
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Targeting atypical protein kinase C iota reduces viability in glioblastoma stem-like cells via a notch signaling mechanism.
    Phillips E; Lang V; Bohlen J; Bethke F; Puccio L; Tichy D; Herold-Mende C; Hielscher T; Lichter P; Goidts V
    Int J Cancer; 2016 Oct; 139(8):1776-87. PubMed ID: 27299852
    [TBL] [Abstract][Full Text] [Related]  

  • 68. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 69. HER2-specific T cells target primary glioblastoma stem cells and induce regression of autologous experimental tumors.
    Ahmed N; Salsman VS; Kew Y; Shaffer D; Powell S; Zhang YJ; Grossman RG; Heslop HE; Gottschalk S
    Clin Cancer Res; 2010 Jan; 16(2):474-85. PubMed ID: 20068073
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Heterogeneous phenotype of human glioblastoma: in vitro study.
    Denysenko T; Gennero L; Juenemann C; Morra I; Masperi P; Ceroni V; Pragliola A; Ponzetto A; Melcarne A
    Cell Biochem Funct; 2014 Mar; 32(2):164-76. PubMed ID: 23836332
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inhibition of Farnesyltransferase Potentiates NOTCH-Targeted Therapy against Glioblastoma Stem Cells.
    Ma Y; Cheng Z; Liu J; Torre-Healy L; Lathia JD; Nakano I; Guo Y; Thompson RC; Freeman ML; Wang J
    Stem Cell Reports; 2017 Dec; 9(6):1948-1960. PubMed ID: 29198824
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Targeted nanocomplex carrying siRNA against MALAT1 sensitizes glioblastoma to temozolomide.
    Kim SS; Harford JB; Moghe M; Rait A; Pirollo KF; Chang EH
    Nucleic Acids Res; 2018 Feb; 46(3):1424-1440. PubMed ID: 29202181
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Precursor States of Brain Tumor Initiating Cell Lines Are Predictive of Survival in Xenografts and Associated with Glioblastoma Subtypes.
    Cusulin C; Chesnelong C; Bose P; Bilenky M; Kopciuk K; Chan JA; Cairncross JG; Jones SJ; Marra MA; Luchman HA; Weiss S
    Stem Cell Reports; 2015 Jul; 5(1):1-9. PubMed ID: 26095605
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The histone deacetylase inhibitor trichostatin a promotes apoptosis and antitumor immunity in glioblastoma cells.
    Höring E; Podlech O; Silkenstedt B; Rota IA; Adamopoulou E; Naumann U
    Anticancer Res; 2013 Apr; 33(4):1351-60. PubMed ID: 23564772
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The NSL Chromatin-Modifying Complex Subunit KANSL2 Regulates Cancer Stem-like Properties in Glioblastoma That Contribute to Tumorigenesis.
    Ferreyra Solari NE; Belforte FS; Canedo L; Videla-Richardson GA; Espinosa JM; Rossi M; Serna E; Riudavets MA; Martinetto H; Sevlever G; Perez-Castro C
    Cancer Res; 2016 Sep; 76(18):5383-94. PubMed ID: 27406830
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid.
    Friedman MD; Jeevan DS; Tobias M; Murali R; Jhanwar-Uniyal M
    Oncol Rep; 2013 Oct; 30(4):1645-50. PubMed ID: 23877261
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Characterization of a FOXG1:TLE1 transcriptional network in glioblastoma-initiating cells.
    Dali R; Verginelli F; Pramatarova A; Sladek R; Stifani S
    Mol Oncol; 2018 Jun; 12(6):775-787. PubMed ID: 29316219
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Functional role of CLIC1 ion channel in glioblastoma-derived stem/progenitor cells.
    Setti M; Savalli N; Osti D; Richichi C; Angelini M; Brescia P; Fornasari L; Carro MS; Mazzanti M; Pelicci G
    J Natl Cancer Inst; 2013 Nov; 105(21):1644-55. PubMed ID: 24115360
    [TBL] [Abstract][Full Text] [Related]  

  • 80. p300- and Myc-mediated regulation of glioblastoma multiforme cell differentiation.
    Panicker SP; Raychaudhuri B; Sharma P; Tipps R; Mazumdar T; Mal AK; Palomo JM; Vogelbaum MA; Haque SJ
    Oncotarget; 2010 Aug; 1(4):289-303. PubMed ID: 21304179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.